BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17275414)

  • 1. Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseases.
    Kibiki GS; van der Ven AJ; Geurts-Moespot A; Shao J; Calandra T; Sweep FC; Dolmans WM
    Clin Immunol; 2007 Apr; 123(1):60-5. PubMed ID: 17275414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage-activating cytokines in human immununodeficiency virus type 1-infected and -uninfected patients with pulmonary tuberculosis.
    Mayanja-Kizza H; Johnson JL; Hirsch CS; Peters P; Surewicz K; Wu M; Nalugwa G; Mubiru F; Luzze H; Wajja A; Aung H; Ellner JJ; Whalen C; Toossi Z
    J Infect Dis; 2001 Jun; 183(12):1805-9. PubMed ID: 11372035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trauma patients with positive cultures have higher levels of circulating macrophage migration inhibitory factor (MIF).
    Joshi PC; Poole GV; Sachdev V; Zhou X; Jones Q
    Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):13-20. PubMed ID: 11334363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary neopterin measurement as a non-invasive diagnostic method in pulmonary tuberculosis.
    Yuksekol I; Ozkan M; Akgul O; Tozkoparan E; Al-Rashed M; Balkan A; Hatipoglu K; Bilgic H; Erbil K; Demirci N
    Int J Tuberc Lung Dis; 2003 Aug; 7(8):771-6. PubMed ID: 12921154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis.
    Bargagli E; Olivieri C; Nikiforakis N; Cintorino M; Magi B; Perari MG; Vagaggini C; Spina D; Prasse A; Rottoli P
    Respir Physiol Neurobiol; 2009 Jul; 167(3):261-7. PubMed ID: 19464392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory diagnosis of pulmonary tuberculosis in TB and HIV endemic settings and the contribution of real time PCR for M. tuberculosis in bronchoalveolar lavage fluid.
    Kibiki GS; Mulder B; van der Ven AJ; Sam N; Boeree MJ; van der Zanden A; Dolmans WM
    Trop Med Int Health; 2007 Oct; 12(10):1210-7. PubMed ID: 17956503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute- phase response and iron status markers among pulmonary tuberculosis patients: a cross-sectional study in Mwanza, Tanzania.
    Friis H; Range N; Braendgaard Kristensen C; Kaestel P; Changalucha J; Malenganisho W; Krarup H; Magnussen P; Bengaard Andersen A
    Br J Nutr; 2009 Jul; 102(2):310-7. PubMed ID: 19175946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic fetal inflammation and reduced concentrations of macrophage migration inhibitory factor in tracheobronchial aspirate fluid of extremely premature infants.
    Thomas W; Seidenspinner S; KawczyƄska-Leda N; Kramer BW; Chmielnicka-Kopaczyk M; Marx A; Szymankiewicz M; Speer CP
    Am J Obstet Gynecol; 2008 Jan; 198(1):64.e1-6. PubMed ID: 18166309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated macrophage migration inhibitory factor (MIF) levels in the urine of patients with focal glomerular sclerosis.
    Matsumoto K; Maruyama N; Maruyama T; Ohnishi Y; Nonaka S; Inoshita A; Ito K; Kitajima S; Abe M; Satomura A; Fujita T
    Clin Exp Immunol; 2005 Feb; 139(2):338-47. PubMed ID: 15654833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis.
    Yamada G; Shijubo N; Takagi-Takahashi Y; Nishihira J; Mizue Y; Kikuchi K; Abe S
    Clin Immunol; 2002 Aug; 104(2):123-7. PubMed ID: 12165273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked elevation of serum macrophage migration inhibitory factor levels in patients with pemphigus vulgaris.
    Namazi MR; Fallahzadeh MK; Shaghelani H; Kamali-Sarvestani E
    Int J Dermatol; 2010 Feb; 49(2):146-8. PubMed ID: 19799642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of macrophage migration inhibitory factor (MIF) prevents the antigen-induced response in a murine model of allergic airway inflammation.
    Amano T; Nishihira J; Miki I
    Inflamm Res; 2007 Jan; 56(1):24-31. PubMed ID: 17334667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of serum macrophage migration inhibitory factor levels in pulmonary tuberculosis.
    Wang Q; Han W; Niu J; Sun B; Dong W; Li G
    Respir Res; 2019 Mar; 20(1):50. PubMed ID: 30841876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increases in serum macrophage migration inhibitory factor in patients with severe sepsis predict early mortality.
    Chuang CC; Wang ST; Chen WC; Chen CC; Hor LI; Chuang AY
    Shock; 2007 May; 27(5):503-6. PubMed ID: 17438455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage migration inhibitory factor is increased in the urine of patients with urinary tract infection: macrophage migration inhibitory factor-protein complexes in human urine.
    Meyer-Siegler KL; Iczkowski KA; Vera PL
    J Urol; 2006 Apr; 175(4):1523-8. PubMed ID: 16516040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased macrophage migration inhibitory factor (MIF) plasma levels in acute HIV-1 infection.
    Delaloye J; De Bruin IJ; Darling KE; Reymond MK; Sweep FC; Roger T; Calandra T; Cavassini M
    Cytokine; 2012 Nov; 60(2):338-40. PubMed ID: 22898393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum macrophage migration inhibitory factor (MIF) in the intercritical phase of hereditary periodic fevers and its relationship with the MIF-173G/C polymorphism.
    Rigante D; Flex A; Federico G; Pola R; Candelli M; Manna R; Pugliese AL; Cerquaglia C; Compagnone A; Stabile A
    Scand J Rheumatol; 2007; 36(4):307-10. PubMed ID: 17763209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential recruitment of phagocytes into the lung of patients with advanced acquired immunodeficiency syndrome and tuberculosis.
    Werneck-Barroso E; Bonecini-de-Almeida MD; Vieira MA; Carvalho CE; Teixeira AK; Kritski AL; Ho JL
    Respir Med; 2000 Jan; 94(1):64-70. PubMed ID: 10714481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease.
    Hoshina T; Kusuhara K; Ikeda K; Mizuno Y; Saito M; Hara T
    Scand J Rheumatol; 2008; 37(6):445-9. PubMed ID: 18720262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin A status of patients presenting with pulmonary tuberculosis and asymptomatic HIV-infected individuals, Dar es Salaam, Tanzania.
    Mugusi FM; Rusizoka O; Habib N; Fawzi W
    Int J Tuberc Lung Dis; 2003 Aug; 7(8):804-7. PubMed ID: 12921158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.